CompletedPhase 4NCT00557232

Intraocular Bevacizumab (Avastin) for Rubeosis Iridis

Studying NON RARE IN EUROPE: Primary adult open-angle glaucoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Instituto de Olhos de Goiania
Principal Investigator
Joao J Nassaralla, Jr.
Instituto de Olhos de Goiânia
Intervention
bevacizumab(drug)
Enrollment
25 enrolled
Eligibility
18-65 years · All sexes
Timeline
20062011

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00557232 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Primary adult open-angle glaucoma

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Primary adult open-angle glaucoma

← Back to all trials